Announced
Synopsis
Incyte, a biotechnology company, agreed to acquire a minority stake in MorphoSys, a biotechnological research company, for $150m. "We are pleased to announce resolving the capital increase, which marks the final step in formalizing our partnership with Incyte. We are grateful for our partner's long-term commitment and are excited to kick off and operationalize our collaboration at full speed over the coming weeks and months," Jens Holstein, MorphoSys CFO.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.